TY - JOUR
T1 - Distress in the time of COVID-19
T2 - Understanding the distinction between COVID-19 specific mental distress and depression among United States adults
AU - Schneider, Kristin E.
AU - Dayton, Lauren
AU - Wilson, Deborah
AU - Nestadt, Paul S.
AU - Latkin, Carl A.
N1 - Funding Information:
Funding: This study was supported by the Alliance for a Healthier World and the National Institute on Drug Abuse (NIDA; R01DA040488). KES was supported by a NIDA training grant (5T32DA007292). PSN is supported by the James Wah Foundation for Mood Disorders and the American Foundation for Suicide Prevention (YIG-0-093-18). The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Publisher Copyright:
© 2021
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Background: During the COVID-19 pandemic, many Americans have experienced mental distress, which may be partially characterized by a rise in mental illnesses. However, COVID-19 specific psychological distress may also be separate from diagnosable conditions, a distinction that has not been well established in the context of the pandemic. Methods: Data came from an online survey of US adults collected in March 2020. We used factor analysis to assess the relationship between COVID-19 related mental distress and depressive symptoms. Using four questions on psychological distress modified for COVID-19 and eight depressive symptoms, we conducted an exploratory factor analysis (EFA) to identify the factor structure and then estimated a confirmatory factor analysis (CFA). Results: The EFA model indicated a two-factor solution, where the COVID-19 distress items loaded onto the first factor and depression items loaded onto the second. Only two items cross-loaded between factors: feeling fearful and being bothered by things that do not usually bother the participant. The CFA indicated that this factor structure fit the data adequately (RMSEA=0.106, SRMR=0.046, CFI=0.915, TLI=0.890). Limitations: It is possible that there are additional important symptoms of COVID-19 distress that were not included. Depression symptoms were measured via the CES-D-10, which while validated is not equivalent to a clinician diagnosis. Conclusions: As COVID-19 related mental distress appears to be distinct from, though related to, depression, public health responses must consider what aspects of depression treatment may apply to this phenomenon. For COVID-related distress, it may be more appropriate to treat symptomatically and with supportive psychotherapy.
AB - Background: During the COVID-19 pandemic, many Americans have experienced mental distress, which may be partially characterized by a rise in mental illnesses. However, COVID-19 specific psychological distress may also be separate from diagnosable conditions, a distinction that has not been well established in the context of the pandemic. Methods: Data came from an online survey of US adults collected in March 2020. We used factor analysis to assess the relationship between COVID-19 related mental distress and depressive symptoms. Using four questions on psychological distress modified for COVID-19 and eight depressive symptoms, we conducted an exploratory factor analysis (EFA) to identify the factor structure and then estimated a confirmatory factor analysis (CFA). Results: The EFA model indicated a two-factor solution, where the COVID-19 distress items loaded onto the first factor and depression items loaded onto the second. Only two items cross-loaded between factors: feeling fearful and being bothered by things that do not usually bother the participant. The CFA indicated that this factor structure fit the data adequately (RMSEA=0.106, SRMR=0.046, CFI=0.915, TLI=0.890). Limitations: It is possible that there are additional important symptoms of COVID-19 distress that were not included. Depression symptoms were measured via the CES-D-10, which while validated is not equivalent to a clinician diagnosis. Conclusions: As COVID-19 related mental distress appears to be distinct from, though related to, depression, public health responses must consider what aspects of depression treatment may apply to this phenomenon. For COVID-related distress, it may be more appropriate to treat symptomatically and with supportive psychotherapy.
UR - http://www.scopus.com/inward/record.url?scp=85111965419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111965419&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2021.07.095
DO - 10.1016/j.jad.2021.07.095
M3 - Article
C2 - 34375223
AN - SCOPUS:85111965419
SN - 0165-0327
VL - 294
SP - 949
EP - 956
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -